| Bioactivity | (R)-PROTAC CDK9 ligand-1 (Compound 19.4) is a CDK9-targeting degrader that can be used to synthesize PROTAC with antitumor activity[1]. |
| Target | CDK9. |
| Name | (R)-PROTAC CDK9 ligand-1 |
| CAS | 2411021-95-7 |
| Formula | C20H28N6O |
| Molar Mass | 368.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xiaohua Chen, et al. Preparation of degradation agents for cyclin dependent kinase useful for the treatment of cancer. Patent CN110835345A. |
(R)-PROTAC CDK9 ligand-1
CAS: 2411021-95-7 F: C20H28N6O W: 368.48
(R)-PROTAC CDK9 ligand-1 (Compound 19.4) is a CDK9-targeting degrader that can be used to synthesize PROTAC with antitum
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.